Impact of Pre-Transplant Hypomethylating Agents on Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome With Good or Intermediate-Risk Cytogenetics
{{output}}
Allogeneic stem cell transplant (Allo-SCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). The benefit of cytoreduction with hypomethylating agents (HMAs) prior to reduced-intensity conditioning (RIC) transplant, particularly... ...
